Heterogeneous FDG-guided dose-escalation for locally advanced NSCLC (the NARLAL2 trial) - Staff at the Niels Bohr Institute

Niels Bohr Institute

Heterogeneous FDG-guided dose-escalation for locally advanced NSCLC (the NARLAL2 trial): Design and early dosimetric results of a randomized, multi-centre phase-III study

Research output: Contribution to journal › Journal article › Research › peer-review

Documents

Heterogeneous_FDG-guided_dose-escalation_for_locally_advanced_NSCLC_2017_accepted
Accepted author manuscript, 180 KB, PDF document

Ditte Sloth Moller
Tine Bjørn Nielsen
Carsten Brink
Lone Hoffmann
Christina Maria Lutz
Mikkel Drogemuller Lund
Olfred Hansen
Tine Schytte
Azza Ahmed Khalil
Marianne Marquard Knap
Christa Haugaard Nyhus
Wiviann Ottosson
Patrik Sibolt
Svetlana Borissova
Josipovic, Mirjana
Persson, Gitte
Ane Lindegaard Appelt

Original language	English
Journal	Radiotherapy & Oncology
Volume	124
Issue number	2
Pages (from-to)	311-317
ISSN	0167-8140
DOIs	https://doi.org/10.1016/j.radonc.2017.06.022
Publication status	Published - Aug 2017

Research areas

NSCLC, Dose-escalation, Randomized phase-III trial

Number of downloads are based on statistics from Google Scholar and www.ku.dk

No data available

ID: 184386819